Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 2018: Canagliflozin & heart failure in type 2 diabetes
Author(s): Gemma Figtree Added: 6 years ago
Gemma Figtree discusses the CANVAS trial - canagliflozin and heart failure in type 2 diabetes mellitus. Filmed by Radcliffe Cardiology on-site at the American College of Cardiology congress 2018 in Orlando, USA. View more

Heart Failure

Prevention & Chronic Conditions
EASD 23: Efinopegdutide in NAFLD & T2D patients
Author(s): Samuel S Engel Added: 6 months ago
EASD 2023 — In this short interview, Dr Samuel S Engel (Associate Vice President at Merck) discusses a study investigating the effectiveness and safety of efinopegdutide (MK-6024) in patients with nonalcoholic fatty liver disease and type 2 diabetes (NCT04944992).The phase IIa study randomized 145 participants (efinopegdutide, n = 72; semaglutide, n = 73). The majority (55.2%) of participants… View more

Prevention & Chronic Conditions
Author(s): Lars Rydén , Linda Mellbin , Klas Malmberg Added: 3 years ago
The worldwide prevalence of diabetes in 2010 is already at epidemic proportions with an estimated 284.6 million adults (aged 20–79 years), representing 6.4% of the global adult population.1 However, more worryingly, the prevalence has increased by 15% since 20072 and projections estimate that 438.4 million adults will have diabetes in 2030, a 54% increase on 2010 figures.1 This drastic rise in… View more

Prevention & Chronic Conditions
Pharmacological Treatment of Type 2 Diabetes and CVD
Author(s): Felipe Martínez Added: 3 years ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Type 2 Diabetes Treatment in Patients with CVD
Author(s): Tariq Ahmad , Ralph J Riello , Silvio Inzucchi Added: 3 years ago

Prevention & Chronic Conditions

CV Disease in Special Populations
APSC Consensus on Optimising CV Outcomes in T2D
Author(s): Jack Wei Chieh Tan , David Sim , Junya Ako , et al Added: 3 years ago

Standards & Guidelines

Prevention & Chronic Conditions
ESC 2018: Use of SGLT2 inhibitors in clinical practice to reduce CV mortality in patients with type 2 diabetes
Author(s): Javed Butler , Stefan Anker Added: 5 years ago
Esc 2018: Use of sglt2 Inhibitors in Clinical Practice to Reduce CV Mortality in Patients With Type 2 Diabetes - Prof Javed Butler & Prof Stefan Anker Filmed on-site at ESC 2018 by Radcliffe Cardiology. View more

Prevention & Chronic Conditions
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Author(s): Sotirios Tsalamandris , Alexios S Antonopoulos , Evangelos Oikonomou , et al Added: 3 years ago
Diabetes is a multifaceted metabolic disorder affecting the glucose status of the human body. Impaired glucose tolerance and hyperglycaemia are the main clinical and diagnostic features and the result of an absolute or relative insulin deficiency or resistance to its action. Chronic hyperglycaemia associated with diabetes can result in end organ dysfunction and failure which can involve the… View more

Prevention & Chronic Conditions
AHA 22: BT001 PIVOTAL: nCBT in Pts with Type II Diabetes
Author(s): Marc P Bonaca Added: 1 year ago
AHA 22 - Dr Marc Bonaca (University of Colorado School of Medicine, Aurora, Colorado, US) joins us to discuss the findings of the BT001 Pivotal Trial, originally presented at AHA 2022. BT001 Pivotal aimed to study the use of a mobile app that delivered nutritional cognitive behavioural therapy (nCBT) for the treatment of type II diabetes. The application targets behaviours which are associated… View more

Digital Health

Prevention & Chronic Conditions
Author(s): Maki Komiyama , Koji Hasegawa Added: 3 years ago
Type 2 diabetes is a major risk factor for the development of cardiovascular disease (CVD) such as MI, and cerebrovascular incidents such as stroke. A substantial body of evidence has indicated that the proper management of blood glucose in people with diabetes can inhibit the progression of microvascular disease such as retinopathy and nephropathy. Nevertheless, whether strict blood glucose… View more

Prevention & Chronic Conditions